Conditions: Osteoporosis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 13
Healthy volunteers: no

Brief summary:
The purpose of this trial is to compare the difference in bone microarchitecture of the distal radius at month 12 in postmenopausal osteopenic women treated with risedronate 150mg taken once a month compared to placebo.

Detailed description:

Arms:
arm 1: one 150 mg risedronate once a month, orally arm 2: Placebo tablet once a month, orally

Interventions: intervention 1: placebo intervention 2: risedronate
Intervention descriptions: intervention 1: oral tablet once a month for 12 months intervention 2: tablet, 150 mg once a month for 12 months

Protocol document: